Partners in Health Research and Development
Thika, Kenya
NCT Number: NCT04424524
This is a pilot facility-based direct-to-pharmacy PrEP refill delivery to streamline care pathway in Kenyan public health HIV facilities implementing PrEP. Data on up to 500 PrEP users will be evaluated to understand delivery efficiency and in-depth interview with users and delivery key informants will be conducted to identify barriers and facilitators of implementation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Thika, Kenya
A prospective, pilot implementation evaluation of patient-centered differentiated care service. The core components of the multifaceted implementation strategy include: 1) 3-monthly refills, 2) direct-to-pharmacy refill visits, 3) HIV self-testing (HIVST) while waiting for refills, 4) Rapid risk assessment for ongoing risk, adherence, side effect, and acute HIV symptoms. Clinics will implement either: 1) current PrEP patient flow without any change or 2) a pilot differentiated pharmacy-based follow up PrEP care pathway. Clinics will implement only one delivery model thus eliminating risk for confusion in the clinic about delivery models and permitting a full-scale test of the system, since the efficiency in PrEP delivery is in part at the system level, above and beyond the individual client encounter. For this pilot project designed to primarily test delivery efficiency, feasibility and acceptability of direct-to-pharmacy care pathway at systems level using existing public health infrastructure, pilot and control clinics will be of comparable size selected to reflect the implementation nature of the design.
The specific aims are:
Aim 1: To evaluate whether a differentiated care model improves the efficiency of PrEP delivery while resulting in equivalent or better: 1) patient waiting time, 2) early PrEP continuation, and 3) adherence.
Aim 2: Conduct mixed-methods study to understand patient and provider perception, experiences , feasibility and acceptability of a differentiated PrEP delivery model.
Aim 3: Assess the efficiency, cost and cost-effectiveness of a facility-based differentiated PrEP care.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For HIV-negative participants:
For Key delivery informants:
Exclusion criteria
Programmatic direct-to-pharmacy oral PrEP refill visits supported with client HIV self-testing
Time frame: up to 6 months
Total waiting time at the clinic and contact time with providers measured by time and motion studies
Time frame: up to 6 months
Measured by return to clinic for PrEP refill
Time frame: up to 6 months
Measured objectively through tenofovir levels in dried blood spots at random subset of PrEP visits
Time frame: up to 6 months
Assessed by the Acceptability of Intervention Psychometric Measure (AIM)
Time frame: up to 6 months
Assessed by the Acceptability of Intervention Psychometric Measure (AIM)
Time frame: up to 6 months
Assessed by the Feasibility of Intervention Psychometric Measure (FIM)
Time frame: up to 6 months
Evaluated through in-depth and key informants qualitative interviews
Time frame: up to 6 months
Evaluated through in-depth and key informants qualitative interviews
Time frame: up to 6 months
Extent to which core components of the direct-to-pharmacy PrEP care pathway are implemented as intended will be evaluated through checklists and surveys with clinic managers
Time frame: up to 6 moths
Accuracy of HIV self-testing measured by frequency false negative and positive tests.
Time frame: up to 6 months
Measured through in-depth qualitative interviews and surveys with persons who discontinue PrEP use
Time frame: up to 6 months
Measured through micro-activity costing and time and motion studies
University of Washington
Other
An Implementation Project to Improve the Efficiency of PrEP Delivery in Public Health HIV Care Clinics in Kenya
Acronym: Efficiency
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06566417
HIV Preexposure Prophylaxis, HIV Prevention
Kisumu, Kenya
View Trial DetailsNCT07133555
HIV Counseling and Testing, HIV Prevention
Baltimore, Maryland, United States
View Trial DetailsNCT05087680
HIV Prevention
Jackson, Mississippi, United States
View Trial DetailsNCT07074899
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Lima, Lima Province, Peru
View Trial Details